US equities |
MU $1,029.83 ▼-0.58% NVDA $229.54 ▼-0.41% SPCX $162.48 ▲+1.19% TSLA $383.01 ▲+2.14% AAPL $336.62 ▼-1.12% SNDK $1,583.46 ▼-1.62% META $718.38 ▼-0.35% AMD $608.38 ▼-1.98%
FinancialContent

Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

40.98 +1.73 (+4.42%)
Delayed Quote Updated: 3:57 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2
...
29 30 31 32 33 34 35 36 Next >
News headline image
Teva Pharmaceutical Industries (TEVA) Q2 2021 Earnings Call Transcript ↗
TEVA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Full News Day ↗
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
News headline image
Teva Stock Falls After COVID-19 Impacts Q2 Top And Bottomline; Lowers FY21 Outlook ↗
Teva Pharmaceutical Industries Ltd Q2 sales reached $3.9 billion, increasing 1% Y/Y or decreasing 2% in local currency terms, missing the consensus of $4.04 billion. 
Via Talk Markets
News headline image
Teva Stock Falls After COVID-19 Impacts Q2 Top And Bottomline; Lowers FY21 Outlook ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 sales reached $3.9 billion, increasing 1% Y/Y or decreasing 2% in local currency terms, missing the consensus of $4.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
News headline image
Earnings Scheduled For July 28, 2021 ↗
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion. • United... 
Via Benzinga
News headline image
50 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the... 
Via Benzinga
News headline image
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Recap: Teva Pharmaceutical Q2 Earnings ↗
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) fell 2.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 7.27%... 
Via Benzinga
News headline image
Teva Reports Second Quarter 2021 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
Banned Merger ↗
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. 
Via Talk Markets
News headline image
Analyzing Teva Pharmaceutical Indus's Unusual Options Activity ↗
On Friday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $8.84. Sentiment: BEARISH Option... 
Via Benzinga
News headline image
Joblessness Surprise ↗
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices. 
Via Talk Markets
News headline image
Panic Attack ↗
The H1 rise in US markets was based on hope for an end to lockdowns. 
Via Talk Markets
News headline image
Understanding Teva Pharmaceutical Indus's Unusual Options Activity ↗
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $8.98. Sentiment... 
Via Benzinga
News headline image
Teva Announces Changes to Executive Management Team
From Teva Pharmaceutical Industries Limited
Via Business Wire
News headline image
“Claw-Back” day ↗
The rally was just as irrational as the selloff. 
Via Talk Markets
News headline image
Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight ↗
Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation's opioid epidemic. 
Via Investor's Business Daily
Topics Lawsuit
News headline image
Delta Defeats Bulls ↗
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
News headline image
Unusual Options Activity Insight: Teva Pharmaceutical Indus ↗
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $8.38. Sentiment: BULLISH Option... 
Via Benzinga
News headline image
Weak Week ↗
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. 
Via Talk Markets
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week... 
Via Benzinga
News headline image
Selloff Round 3 ↗
Stocks fell across the board in foreign countries, except for Britain which was upbeat. 
Via Talk Markets
News headline image
Yellow Card ↗
The price of oil fell about 1% today. 
Via Talk Markets
News headline image
Analyzing Teva Pharmaceutical Indus's Unusual Options Activity ↗
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved up to $9.31. Sentiment: BEARISH Option... 
Via Benzinga
News headline image
Recovery Friday ↗
The big winners this week were Financials. 
Via Talk Markets
News headline image
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts ↗
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop. 
Via Investor's Business Daily
News headline image
Sell Sell Sell ↗
Today the inevitable reversal of wild gains overtook Wall Street, echoing what occurred in major foreign markets Monday. 
Via Talk Markets
News headline image
People Needed ↗
If qualified people are not looking for work, they will have to be lured to do so with higher wages. 
Via Talk Markets
News headline image
Teva Recalls One Batch Of Topotecan After Complaint Of Glass Particulate In Vial ↗
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is recalling one lot of its cancer drug topotecan injection after a pharmacy complaint flagged the presence of a single glass... 
Via Benzinga
Topics Product Recall
< Previous 1 2
...
29 30 31 32 33 34 35 36 Next >